iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
iNtRON Biotechnology Dividend Announcement
• iNtRON Biotechnology announced a annually dividend of ₩100.00 per ordinary share which will be made payable on 2025-04-16. Ex dividend date: 2024-12-27
• iNtRON Biotechnology annual dividend for 2024 was ₩100.00
• iNtRON Biotechnology annual dividend for 2023 was ₩100.00
• iNtRON Biotechnology's trailing twelve-month (TTM) dividend yield is 2.16%
• iNtRON Biotechnology's payout ratio for the trailing twelve months (TTM) is -68.92%
iNtRON Biotechnology Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-12-27 | ₩100.00 | annually | 2025-04-16 |
| 2023-12-27 | ₩100.00 | annually | 2024-04-16 |
iNtRON Biotechnology Dividend per year
iNtRON Biotechnology Dividend Yield
iNtRON Biotechnology current trailing twelve-month (TTM) dividend yield is 2.16%. Interested in purchasing iNtRON Biotechnology stock? Use our calculator to estimate your expected dividend yield:
iNtRON Biotechnology Financial Ratios
P/E ratio-32.61
PEG ratio-0.25
P/B ratio1.76
ROE-5.18%
Payout ratio-68.92%
Current ratio51.05
Quick ratio51.05
Cash Ratio0.00
iNtRON Biotechnology Dividend FAQ
Does iNtRON Biotechnology stock pay dividends?
iNtRON Biotechnology does not currently pay dividends to its shareholders.
Has iNtRON Biotechnology ever paid a dividend?
No, iNtRON Biotechnology has no a history of paying dividends to its shareholders. iNtRON Biotechnology is not known for its dividend payments.
Why doesn't iNtRON Biotechnology pay dividends?
There are several potential reasons why iNtRON Biotechnology would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will iNtRON Biotechnology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While iNtRON Biotechnology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is iNtRON Biotechnology a dividend aristocrat?
iNtRON Biotechnology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is iNtRON Biotechnology a dividend king?
iNtRON Biotechnology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is iNtRON Biotechnology a dividend stock?
No, iNtRON Biotechnology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy iNtRON Biotechnology stocks?
To buy iNtRON Biotechnology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy iNtRON Biotechnology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy iNtRON Biotechnology stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.